SLC7A4 is a solute carrier family 7 member localized to chromosome 22.2 that encodes a cationic amino acid transporter. The protein is structurally homologous to confirmed cationic amino acid transporters (CAT-1, CAT-2, CAT-3) 1 and shows abundant expression in brain, testis, and placenta 1. However, SLC7A4's functional role remains controversial. Early Xenopus oocyte studies suggested cationic amino acid transport capacity 1, but subsequent research demonstrated that SLC7A4 plasma membrane expression alone is insufficient to mediate transport of cationic, neutral, or anionic amino acids 2. Recent structural studies reveal SLC7A4 functions as a pH-regulated leucine transporter in human cells through an allosteric mechanism linking ligand recognition to proton regulation 3. Functionally, arginine transport via SLC7A4 could not be convincingly demonstrated 4. SLC7A4 has clinical relevance in velocardiofacial syndrome, mapping to the commonly deleted 22q11.2 region 1, and frameshift variants have been identified in classic bladder exstrophy patients 5. Additionally, SLC7A4 expression is significantly upregulated in obese mouse testes in Sertoli cells, suggesting involvement in obesity-related testicular dysfunction 6.